Part, Chapter, Paragraph
1 II, 5. 2. 5| highlights the importance of decisions such as stop smoking, adopting
2 II, 5. 2. 6| to wrong conclusions and decisions if not properly controlled
3 II, 5. 3. 7| required to make the best decisions for each patient’s diagnosis,
4 II, 5. 5. 2| they need assistance making decisions. At this time, a legal guardian
5 II, 5. 5. 3| create a firm basis for decisions and strategies regarding
6 II, 5. 5. 3| Database~Since strategies and decisions should be backed up by reliable
7 II, 5. 7. 6| stakeholders in guiding their decisions. The NephroQUEST project
8 II, 6. 3. 2| involves important political decisions, specific legislation and
9 II, 6. 4. 2| the system. Under these decisions, Member States should inform
10 II, 9. 1. 2| termination necessitates decisions on which anomalies justify
11 II, 9. 1. 2| European information system – decisions on funding are short-term.
12 II, 9. 2. 1| health-related behavioural decisions), they nevertheless remain
13 II, 9. 2. 1| blame them for making wrong decisions, many commercial interests
14 II, 9. 2. 5| thirty directives, framework decisions or green papers have been
15 II, 9. 4. 5| considerations into their decisions. A process of mutual learning
16 III, 10. 2. 1| which include authoritative decisions that are made by governments
17 III, 10. 3. 1| findings and more informed decisions. Protecting human health
18 III, 10. 4. 2| open to risk managers when decisions have to be made to protect
19 III, 10. 4. 2| assessment process. This affects decisions on:~ ~· The choice of qualitative
20 III, 10. 5. 1| health and that the policy decisions can have a positive or a
21 III, 10. 6. 2| and by taking political decisions at different levels. The
22 IV, 11. 1. 6| reimbursement rates also requires decisions to be made about outlier
23 IV, 11. 2. 2| systematic procedure for making decisions affecting public health,
24 IV, 11. 2. 2| methodology used for making decisions and setting priorities in
25 IV, 11. 2. 2| evidence to support policy decisions and evaluate the effectiveness
26 IV, 11. 3. 2| wide range of regulatory decisions about market authorization,
27 IV, 11. 3. 2| linked to reimbursement decisions by setting a maximum level
28 IV, 11. 3. 2| 2006).~ ~Reimbursement decisions about whether and at what
29 IV, 11. 3. 2| and the payer, and policy decisions regarding cost-sharing arrangements.
30 IV, 11. 3. 2| used to make reimbursement decisions, e.g. in Finland and the
31 IV, 11. 3. 2| analysis is used to inform decisions about reimbursement, but
32 IV, 11. 4 | define policies nor make decisions. There is a clear distinction
33 IV, 11. 4 | committees to inform its decisions, and are made publicly available
34 IV, 11. 4 | reached its preliminary decisions. The assessment does not
35 IV, 11. 6. 2| electorate and allocation decisions may be more apparent; and
36 IV, 11. 6. 4| so for pharmaceuticals. Decisions regarding benefit catalogues
37 IV, 11. 6. 4| reports, to support various decisions surrounding a given health
38 IV, 11. 6. 4| reimbursement and pricing decisions often differ from those
39 IV, 11. 6. 4| political will to enforce the decisions based on HTA. The trend
40 IV, 11. 6. 5| Shifting criteria for benefit decisions in social health insurance
41 IV, 11. 6. 5| into Health Care Purchasing Decisions? New York, The Commonwealth
42 IV, 11. 6. 5| resource allocation and funding decisions. Funding health care: options
43 IV, 12. 1 | of integrated regulatory decisions about good clinical practice
44 IV, 12. 2 | which include authoritative decisions that are made by governments
45 IV, 12. 4 | charge of all health related decisions. Similarly, the work of
46 IV, 12. 7 | health can be influenced by decisions made in sectors other than
47 IV, 12. 7 | the health impact of such decisions, so that health is systematically
48 IV, 12. 10 | implement the Strategy. The decisions of the HSE in relation to
49 IV, 12. 10 | According Ministerial Decisions 76017 (1-8-2002) and 82942 (
50 IV, 12. 10 | organisms.~o Ministerial Decisions 34258 and 100 (published
51 IV, 12. 10 | etc.)~Air pollution~ High~Decisions 346-352/03/2007 regarding
52 IV, 12. 10 | pesticides~ high~Law 89/2006 and decisions on maximum admitted levels
53 IV, 12. 10 | municipalities had made decisions on municipal merges, reducing
54 IV, 13.Acr | methodology used for making decisions and setting priorities in
55 IV, 13. 3 | define priorities, support decisions and evaluate cost-effectiveness
